Vertex Pharma (VRTX) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $468.42 +0.35%
EPS Growth %: +4.4%
Financial Fact:
Collaborative revenues: 259K
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +4.4%
Financial Fact:
Collaborative revenues: 259K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q1 EPS of ($0.62), $0.13 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $138.5 million versus the consensus estimate of $142.38 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- CVG to join Russell 2000 and Russell 3000 indexes June 26
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
